Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease

J. L. Gajewski, G. L. Phillips, K. A. Sobocinski, J. O. Armitage, R. P. Gale, R. E. Champlin, R. H. Herzig, D. D. Hurd, S. Jagannath, J. P. Klein, H. M. Lazarus, P. L. McCarthy, S. Pavlovsky, F. B. Peterson, P. A. Rowlings, J. A. Russell, S. M. Silver, J. M. Vose, P. H. Wiernik, M. M. Bortin & 1 others M. M. Horowitz

Research output: Contribution to journalArticle

171 Citations (Scopus)

Abstract

Purpose: To determine the outcome of HLA-identical sibling bone marrow transplants in advanced Hodgkin's disease. Patients and Methods: We reviewed the data on 100 consecutive patients with Hodgkin's disease who received HLA- identical sibling bone marrow transplants between April 1, 1982 and August 12, 1992, reported to the International Bone Marrow Transplant Registry (IBMTR). The median interval from diagnosis to transplant was 2.5 years (range, <1 to 14). All had advanced disease. Eighty-nine of 100 patients were not in remission at the time of transplant. Fifty had pretransplant Karnofsky scores less than 90% and 27 had active infection in the week before transplant. Patients received o variety of conditioning regimens; 45 received total-body radiation. Results: The 100-day probability of acute graft- versus-host disease (GVHD) was 35% (95% confidence interval [CI], 26% to 46%); the 3-year probability of chronic GVHD was 45% (95% CI, 31% to 59%). The 3-year probability of relapse was 65% (95% CI, 50% to 78%). The 3-year probability of survival was 21% (95% CI, 14% to 30%). The 3-year disease- free survival rate was 15% (95% CI, 9% to 24%). Conclusion: HLA-identical sibling bone marrow transplants have a limited role in advanced Hodgkin's disease.

Original languageEnglish (US)
Pages (from-to)572-578
Number of pages7
JournalJournal of Clinical Oncology
Volume14
Issue number2
StatePublished - Feb 1996
Externally publishedYes

Fingerprint

Hodgkin Disease
Siblings
Bone Marrow
Transplants
Confidence Intervals
Graft vs Host Disease
Disease-Free Survival
Registries
Survival Rate
Radiation
Recurrence
Survival
Infection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gajewski, J. L., Phillips, G. L., Sobocinski, K. A., Armitage, J. O., Gale, R. P., Champlin, R. E., ... Horowitz, M. M. (1996). Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. Journal of Clinical Oncology, 14(2), 572-578.

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. / Gajewski, J. L.; Phillips, G. L.; Sobocinski, K. A.; Armitage, J. O.; Gale, R. P.; Champlin, R. E.; Herzig, R. H.; Hurd, D. D.; Jagannath, S.; Klein, J. P.; Lazarus, H. M.; McCarthy, P. L.; Pavlovsky, S.; Peterson, F. B.; Rowlings, P. A.; Russell, J. A.; Silver, S. M.; Vose, J. M.; Wiernik, P. H.; Bortin, M. M.; Horowitz, M. M.

In: Journal of Clinical Oncology, Vol. 14, No. 2, 02.1996, p. 572-578.

Research output: Contribution to journalArticle

Gajewski, JL, Phillips, GL, Sobocinski, KA, Armitage, JO, Gale, RP, Champlin, RE, Herzig, RH, Hurd, DD, Jagannath, S, Klein, JP, Lazarus, HM, McCarthy, PL, Pavlovsky, S, Peterson, FB, Rowlings, PA, Russell, JA, Silver, SM, Vose, JM, Wiernik, PH, Bortin, MM & Horowitz, MM 1996, 'Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease', Journal of Clinical Oncology, vol. 14, no. 2, pp. 572-578.
Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE et al. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. Journal of Clinical Oncology. 1996 Feb;14(2):572-578.
Gajewski, J. L. ; Phillips, G. L. ; Sobocinski, K. A. ; Armitage, J. O. ; Gale, R. P. ; Champlin, R. E. ; Herzig, R. H. ; Hurd, D. D. ; Jagannath, S. ; Klein, J. P. ; Lazarus, H. M. ; McCarthy, P. L. ; Pavlovsky, S. ; Peterson, F. B. ; Rowlings, P. A. ; Russell, J. A. ; Silver, S. M. ; Vose, J. M. ; Wiernik, P. H. ; Bortin, M. M. ; Horowitz, M. M. / Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. In: Journal of Clinical Oncology. 1996 ; Vol. 14, No. 2. pp. 572-578.
@article{f97e8c17a9df413babe5bce935cf5acf,
title = "Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease",
abstract = "Purpose: To determine the outcome of HLA-identical sibling bone marrow transplants in advanced Hodgkin's disease. Patients and Methods: We reviewed the data on 100 consecutive patients with Hodgkin's disease who received HLA- identical sibling bone marrow transplants between April 1, 1982 and August 12, 1992, reported to the International Bone Marrow Transplant Registry (IBMTR). The median interval from diagnosis to transplant was 2.5 years (range, <1 to 14). All had advanced disease. Eighty-nine of 100 patients were not in remission at the time of transplant. Fifty had pretransplant Karnofsky scores less than 90{\%} and 27 had active infection in the week before transplant. Patients received o variety of conditioning regimens; 45 received total-body radiation. Results: The 100-day probability of acute graft- versus-host disease (GVHD) was 35{\%} (95{\%} confidence interval [CI], 26{\%} to 46{\%}); the 3-year probability of chronic GVHD was 45{\%} (95{\%} CI, 31{\%} to 59{\%}). The 3-year probability of relapse was 65{\%} (95{\%} CI, 50{\%} to 78{\%}). The 3-year probability of survival was 21{\%} (95{\%} CI, 14{\%} to 30{\%}). The 3-year disease- free survival rate was 15{\%} (95{\%} CI, 9{\%} to 24{\%}). Conclusion: HLA-identical sibling bone marrow transplants have a limited role in advanced Hodgkin's disease.",
author = "Gajewski, {J. L.} and Phillips, {G. L.} and Sobocinski, {K. A.} and Armitage, {J. O.} and Gale, {R. P.} and Champlin, {R. E.} and Herzig, {R. H.} and Hurd, {D. D.} and S. Jagannath and Klein, {J. P.} and Lazarus, {H. M.} and McCarthy, {P. L.} and S. Pavlovsky and Peterson, {F. B.} and Rowlings, {P. A.} and Russell, {J. A.} and Silver, {S. M.} and Vose, {J. M.} and Wiernik, {P. H.} and Bortin, {M. M.} and Horowitz, {M. M.}",
year = "1996",
month = "2",
language = "English (US)",
volume = "14",
pages = "572--578",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "2",

}

TY - JOUR

T1 - Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease

AU - Gajewski, J. L.

AU - Phillips, G. L.

AU - Sobocinski, K. A.

AU - Armitage, J. O.

AU - Gale, R. P.

AU - Champlin, R. E.

AU - Herzig, R. H.

AU - Hurd, D. D.

AU - Jagannath, S.

AU - Klein, J. P.

AU - Lazarus, H. M.

AU - McCarthy, P. L.

AU - Pavlovsky, S.

AU - Peterson, F. B.

AU - Rowlings, P. A.

AU - Russell, J. A.

AU - Silver, S. M.

AU - Vose, J. M.

AU - Wiernik, P. H.

AU - Bortin, M. M.

AU - Horowitz, M. M.

PY - 1996/2

Y1 - 1996/2

N2 - Purpose: To determine the outcome of HLA-identical sibling bone marrow transplants in advanced Hodgkin's disease. Patients and Methods: We reviewed the data on 100 consecutive patients with Hodgkin's disease who received HLA- identical sibling bone marrow transplants between April 1, 1982 and August 12, 1992, reported to the International Bone Marrow Transplant Registry (IBMTR). The median interval from diagnosis to transplant was 2.5 years (range, <1 to 14). All had advanced disease. Eighty-nine of 100 patients were not in remission at the time of transplant. Fifty had pretransplant Karnofsky scores less than 90% and 27 had active infection in the week before transplant. Patients received o variety of conditioning regimens; 45 received total-body radiation. Results: The 100-day probability of acute graft- versus-host disease (GVHD) was 35% (95% confidence interval [CI], 26% to 46%); the 3-year probability of chronic GVHD was 45% (95% CI, 31% to 59%). The 3-year probability of relapse was 65% (95% CI, 50% to 78%). The 3-year probability of survival was 21% (95% CI, 14% to 30%). The 3-year disease- free survival rate was 15% (95% CI, 9% to 24%). Conclusion: HLA-identical sibling bone marrow transplants have a limited role in advanced Hodgkin's disease.

AB - Purpose: To determine the outcome of HLA-identical sibling bone marrow transplants in advanced Hodgkin's disease. Patients and Methods: We reviewed the data on 100 consecutive patients with Hodgkin's disease who received HLA- identical sibling bone marrow transplants between April 1, 1982 and August 12, 1992, reported to the International Bone Marrow Transplant Registry (IBMTR). The median interval from diagnosis to transplant was 2.5 years (range, <1 to 14). All had advanced disease. Eighty-nine of 100 patients were not in remission at the time of transplant. Fifty had pretransplant Karnofsky scores less than 90% and 27 had active infection in the week before transplant. Patients received o variety of conditioning regimens; 45 received total-body radiation. Results: The 100-day probability of acute graft- versus-host disease (GVHD) was 35% (95% confidence interval [CI], 26% to 46%); the 3-year probability of chronic GVHD was 45% (95% CI, 31% to 59%). The 3-year probability of relapse was 65% (95% CI, 50% to 78%). The 3-year probability of survival was 21% (95% CI, 14% to 30%). The 3-year disease- free survival rate was 15% (95% CI, 9% to 24%). Conclusion: HLA-identical sibling bone marrow transplants have a limited role in advanced Hodgkin's disease.

UR - http://www.scopus.com/inward/record.url?scp=9044237273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044237273&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 572

EP - 578

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 2

ER -